A systematic review of adult pineoblastoma

Xiufeng Chu1,2, Ting Zhang1, Helen Benghiat3

  • 1Department of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Frontiers in Oncology
|December 31, 2024
PubMed
Abstract

Insights

This systematic review found that gross total resection and radiotherapy significantly improve survival rates for adult pineoblastoma patients. These findings offer crucial guidance for treating this rare central nervous system malignancy.

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Radiation Oncology

Background:

  • Adult pineoblastoma is an extremely rare central nervous system (CNS) malignancy.
  • Existing data from tumour databases and single-institution studies are insufficient to guide treatment decisions.
  • A systematic review is necessary to consolidate research and provide evidence-based treatment options.

Purpose of the Study:

  • To systematically review existing research data on adult pineoblastoma.
  • To identify effective treatment strategies and prognostic factors for adult pineoblastoma.
  • To provide referenceable treatment options for this rare CNS malignancy.

Main Methods:

  • A systematic literature search was conducted using MEDLINE and Embase with terms "pineoblastoma" and "adult".
  • Relevant articles and their references were reviewed to supplement the systematic search.
  • Data were analyzed using Kaplan-Meier survival curves, COX analysis, chi-square tests, and log-rank tests.

Main Results:

  • The study included 108 adult cases from 32 articles, with a median age of 30 years.
  • Five-year and 10-year survival rates were 49.5% and 33.9%, respectively.
  • Gross total resection (P=0.018), radiotherapy (P<0.001), and chemotherapy (P=0.020) were associated with improved survival. Radiotherapy was an independent prognostic factor (P<0.001).

Conclusions:

  • Gross total excision and radiotherapy demonstrate significant benefits for improving survival in adult pineoblastoma.
  • These findings underscore the importance of aggressive surgical resection and adjuvant radiotherapy in managing adult pineoblastoma.
  • Further research may refine treatment protocols for this rare CNS tumor.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...